Register for email alerts and news feeds:
This journal | BMJ Group
rss
Tob Control. Published Online First: 2 April 2009. doi:10.1136/tc.2008.028993
Copyright © 2009 by the BMJ Publishing Group Ltd.

RESEARCH PAPERS

Evaluating the Acute Effects of Oral, Non-combustible Potential Reduced Exposure Products Marketed to Smokers

Caroline O Cobb, Michael F Weaver, Thomas Eissenberg

Virginia Commonwealth University, United States

E-mail: teissenb{at}vcu.edu

ABSTRACT

Background: Non-combustible potential reduced exposure products (PREPs; e.g., Star Scientific’s Ariva; a variety of other smokeless tobacco products) are marketed to reduce the harm associated with smoking. This marketing occurs despite an absence of objective data concerning the toxicant exposure and effects of these PREPs. This study adapted methods used to examine combustible PREPs to assess the acute effects of non-combustible PREPs for smokers.

Methods: Twenty-eight overnight abstinent cigarette smokers (17 men; 14 non-white) each completed seven, Latin-squared ordered, approximately 2.5-hour laboratory sessions that differed by product administered: Ariva, Marlboro snus (Philip Morris USA), Camel snus (RJ Reynolds), Commit nicotine lozenge (GlaxoSmithKline; 2 mg), own brand cigarettes, Quest cigarettes (Vector Tobacco; delivers very low levels of nicotine), and sham smoking (i.e., puffing on an unlit cigarette). In each session the product was administered twice (separated by 60 minutes), and plasma nicotine levels, expired air CO, and subjective effects were assessed regularly.

Results: Results indicated that the non-combustible products delivered less nicotine than own brand cigarettes, did not expose smokers to CO, and failed to suppress tobacco abstinence symptoms as effectively as combustible products.

Conclusions: While decreased toxicant exposure is a potential indicator of harm reduction potential, a failure to suppress abstinence symptoms suggests that currently marketed non-combustible PREPs may not be a viable harm reduction strategy for U.S. smokers. This study demonstrates how clinical laboratory methods can be used to evaluate the short-term effects of non-combustible PREPs for smokers.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

eLetters:

Read all eLetters

Questionable PREP selection
Hank H Stocker
Tobacco Control Online, 24 Jul 2009 [Full text]

This Article

Services
Citing Articles
Google Scholar
PubMed
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.